/ Active, not recruiting临床2/3期 A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee osteoarthritis pain.
Study details include:
* The study duration will be up to 31 weeks per participant
* The treatment duration will be 6 weeks.
* The visit frequency will be twice weekly during treatment.
* The visit frequency will be every 4 weeks during the follow-up period.
100 项与 Paradigm Biopharmaceuticals (USA), Inc. 相关的临床结果
0 项与 Paradigm Biopharmaceuticals (USA), Inc. 相关的专利（医药）
100 项与 Paradigm Biopharmaceuticals (USA), Inc. 相关的药物交易
100 项与 Paradigm Biopharmaceuticals (USA), Inc. 相关的转化医学
